chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea
Clinical narrative: This case was reported by a physician and described the occurrence of shortness of breath in a female subject aged between 50 and 59 years old who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The reporter is a radiologist. On 10 November 2005 the subject received 1st dose of Fluarix (lot number not provided). On 10 November 2005 4 hours after vaccination with Fluarix, the subject experienced shortness of breath. The subject was seen on 10 November 2005 by the reporting physician for a chest x-ray. The chest x-ray results were not provided. The outcome of the shortness of breath was not reported.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Rash, Urticaria
Clinical narrative: This case was reported by a physician and described the occurrence of exanthema in a 47 year old male subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On 16 October 2005 the subject received 1st dose of Fluarix (lot number and site of injection not provided). On 21 October 2005, 5 days after vaccination with Fluarix, the subject experienced "exanthem consisting of urticarial papules on the neck, face and upper trunk." The subject was seen at a physician's office and was treated with prednisone. The physician reported that "laboratory test results including complete blood count, chemistry profile, serology for valley fever or cocci, and IgE levels were all normal." The outcome of the events was not reported. The physician considered the events to possibly be related to vaccination with Fluarix.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This case was reported by a nurse and described the occurrence of injection site pain in a 50 year old female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The subject's medical history included hypertension. Concurrent medications included Amlodipine (Norvasc) and Multivitamins (Multivitamin). The subject had no illness at the time of vaccination with Fluarix. On 09 November 2005 at 9:00 a.m., the subject received a dose of Fluarix in the left deltoid (lot AFLUA120AA). A previous dose of influenza virus vaccine (unknown manufacturer) was administered on 04 December 2003. On 09 November 2005, 10 minutes after vaccination with Fluarix, the subject experienced "a constant dull pain (4 on a pain scale of 1-10) in the left deltoid and shooting pain (5 on a pain scale of 1-10) on the left side of neck with flexion." The subject "took 600 mg ibuprofen (Motrin)." On 11 November 2005, at an unspecified time in the morning, the subject awoke with "dull pain." The subject "took 400 mg Motrin and was pain free by the afternoon" of 11 November 2005. The nurse considered the events to be related to vaccination of Fluarix.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: This case was reported by a consumer and described the occurrence of arm tingling in a 37 year old male subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The reporter is the subject. A physician or other health care professional has not verified this report. The subject's medical history included "altered sensation of the left side since 28 May 1995." The subject had no concurrent illness at the time of vaccination with Fluarix. Concurrent medications included Naproxen for an unspecified indication. On 15 November 2005 at 2:55 p.m., the subject received 1st dose of Fluarix in the left deltoid (lot AFLUA120AA). "Immediately upon receipt of the injection" of Fluarix, on 15 November 2005, at 2:55 p.m., the subject experienced left arm tingling and feeling of arm and hand falling asleep. The reporter stated that, the subject received "no treatment." The outcome of the events was not reported. Follow up received states - This case was reported by a consumer and described the occcurrence of arm tingling in a 37-year-old male subject who was vaccinated with FLUARIX, GlaxoSmithKline. The initial reporter is the subject. This case was subsequently confirmed by a nurse practitioner. The subject's medical history included arthritis and an "altered sensation of the left side since 28 May 1995." The subject had no concurrent illness at the time if vaccination with FLUARIX. Concurrent medications include Naproxen for arthritis. On 15 November 2005 at 2:55 p.m. the subject received 1st dose of FLUARIX in the left deltoid (Lot AFLUA120AA). "Immediately upon receipt of the inhection" of FLUARIX, on 15 November 2005, at 2:55 P.M., the subject expereinced left arm tingling, feeling of arm and hand falling asleep, and numbness and tingling of the tongue "without any oral swelling." The subject was treated with BENADRYL on 15 November 2005. The events resolved on 16 November 2005. The nurse practitioner considered the events to probably be related to vaccination with FLUARIX and also related to his medical history.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased
Clinical narrative: This case was reported by a nurse and described the occurrence of limited range of motion in arm in a 30 year old female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. There were no concurrent medications. On 08 November 2005 the subject received 1st dose of Fluarix in the right arm (lot AFLUA148AA). On 08 November 2005, less than one day after vaccination with Fluarix, the subject experienced limited range of motion in the right arm. At the time of initial reporting, 29 November 2005, the outcome of the event was not provided. The nurse considered the event to possibly be related to vaccination with Fluarix.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Joint range of motion decreased
Clinical narrative: This case was reported by a nurse and described the occurrence of limited rang of motion in arm in a 50 year old female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. Medical history included tendonitis. There were no concurrent medications. On 09 November 2005 the subject received 1st dose of Fluarix in the left arm (lot number not provided). On 09 November 2005, less than one day after vaccination with Fluarix, the subject experienced limited range of motion and discomfort in the left arm. At the time of initial reporting, 29 November 2005, the outcome of the events was not provided. The nurse considered the events to possible be related to vaccination with Fluarix.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Joint range of motion decreased
Clinical narrative: This case was reported by a nurse and described the occurrence of limited range of motion in arm in a 50 year old female subject who was vaccinated with influenza virus vaccine for prophylaxis. There were no concurrent medications. On 11/04/05 the subject received 1st dose of Fluarix in the left arm. On 11/04/05, less than one day after vaccination with Fluarix, the subject experienced limited range of motion in the left arm. At the time of initial reporting, 11/29/05, the outcome of the event was not provided. The nurse considered the event to possibly be related to vaccination with Fluarix.
Sex: U
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This case was reported by a pharmacist and described the occurrence of injection site soreness in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis.  On an unspecified date on or after 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in October 2005, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The injection site soreness resolved on an unspecified date on or before 11/28/05.
Sex: U
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This case was reported by a pharmacist  and described the occurrence of injection site soreness in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis. On an unspecified date on or after 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in 10/05, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The subject "sought medical attention." The injection site soreness resolved on an unspecified date on or before 11/28/05.
Sex: U
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This case was reported by a pharmacist  and described the occurrence of injection site soreness in an adult  subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis. On an unspecified date on or after 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in 10/05, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The injection site soreness resolved on an unspecified date on or before 11/28/05.
Sex: U
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This case was reported by a pharmacist and described the occurrence of injection site soreness in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine for prophylaxis. On an unspecified date on or before 10/18/05 and on or before 10/28/05 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in 10/05, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The injection site soreness resolved on an unspecified date on or before 11/28/05.
Sex: U
Vaccine: FLU3
Symptoms: Injection site reaction, Myalgia
Clinical narrative: This case was reported by a pharmacist and described the occurrence of injection site soreness in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date on or after 18 October 2005 and on or before 28 October 2005 the subject received a dose of Fluarix. The site of injection of the Fluarix was not provided. On an unspecified date in October 2005, less than one month after vaccination with Fluarix, the subject experienced injection site soreness. The injection site soreness resolved on an unspecified date on or before 28 November 2005. The nurse reported that 7 other subjects experienced adverse events following the administration of Fluarix. Please see cases A0583939A, A0583942A, A0583943A, A0583944A, A0583945A, A0583947A, and A0583948A
Sex: U
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: This case was reported by a pharmacist and described the occurrence of rash in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date on or after 18 October 2005 and on or before 28 October 2005 the subject received a dose of Fluarix. On an unspecified date in October 2005, less than one month after vaccination with Fluarix, The subject experienced rash. The rash resolved on an unspecified date on or before 28 November 2005. The nurse reported that 7 other subjects experienced adverse events following the administration of Fluarix. Please see cases A0583939A, A0583942A, A0583943A, A0583944A, A0583945A, A0583946A, and A0583948A.
Sex: U
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: This case was reported by a pharmacist and described the occurrence of rash in an adult subject of unspecified gender who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. On an unspecified date on or after 18 October 2005 and on or before 28 October 2005 the subject received a dose of Fluarix. On an unspecified date in October 2005, less than one month after vaccination with Fluarix, the subject experienced rash. The rash resolved on an unspecified date on or before 28 November 2005. The nurse reported that 7 other subjects experienced adverse events following the administration of Fluarix. Please see cases A0583939A, A0583942A, A0583943A, A0583944A, A0583945A, A0583946A, and A0583947A.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Amnesia, Confusional state, Encephalitis, Fatigue
Clinical narrative: Seriousness Criteria other medically significant (OMIC). Initial case received from a health care professional on 10/31/2005. A fifteen year old female patient with no pre existing medical conditions received an intramuscular left deltoid injection of Menactra, lot number U1808AA on Sept 27 2005.Twenty four days later, she experienced confusion, memory loss and was very tired. Per the reporter, the patient had been an A student and was not failing test and could not remember the number of days in a year. The patient was examined by a physician and found to have no weakness and her neurologic exam was within normal limits. A CT scan was also normal. She was scheduled for an EEG and an MRI. At the time of this report, the recovery status was not reported. Follow up information received on 12/19/2005 from the responsible physician. Based upon the new information provided, this case is being upgraded to serious. It was reported that the patient was diagnosed with meningoencephalitis. A spinal tap and MRI was completed, but no results were provided. At the time of this report the patient had not recovered from the events.
Age: 1.16
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Cognitive disorder, Speech disorder
Clinical narrative: An 18 month old male was enrolled in a open label study (208109232) for prophylaxis treatment of hepatitis A, had received a fourth intra muscular injection of ActHib, lot number UA858AA (SA lot number W12932), in the right lower thigh and a fourth intra muscular injection of another manufacturers diphtheria, tetanus, acellular pertussis vaccine (Infanrix lot number DTPA592A9), in the right thigh on Jan 15 2005. He also received a subsequent intramuscular injection of another manufacturers hepatitis A vaccine Havrix, batch number VHA776A2, (site not reported) on Feb 28 2005. On May 24 2005, four months after the fourth dose of Infanrix, four months after the fourth dose of ActHib, 85 days after the first of Havrix, this 18 month old subject was observed to experience delayed expressive language abilities. On Oct 26 2005, the child was evaluated with a cognitive delay of eight months of age, receptive delay at ten months level and expressive delay at thirteen months level. Per the reporter, after test results, it was decided to withdraw the subject from the study. The investigator considered that there was a reasonable possibility that the delayed expressive language abilities may have been caused by Infanrix, ActHib and Havrix. Per the reporter, this case is also linked to case B0400912A (twins) who suffered the same SAE. No information was received concerning the linked case with this report. The subject had recovered at the time of this report.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Myalgia, Myocardial ischaemia, Pain, Pericarditis
Clinical narrative: Seriousness criteria Other medically significant (OMIC). Initial report received from a consumer, who is a physician, on Dec 13/2005. A 62 year old male patient with no significant past medical history, received a dose of Fluzone SV 2005-2006 USP, lot number unknown, in the left deltoid on Nov 29 2005. The route of administration was not reported. Two to three hours post vaccination, the patient experienced myalgias in his neck and shoulder area, which were followed by pain from his neck to chest with deep inspiration. The symptoms resolved by the following day. The symptoms reoccurred on Dec 6 2005 and resolved by Dec 7 2005. On Dec 10 2005, the patient again developed the same symptoms, but had more severe crushing chest pain. The patient was seen in an ER that day and an electrocardiogram was suggestive of pericarditis. He had EKG changes that suggested acute ischemia and he was transported via helicopter to a heart center. The EKG changes reverted to normal within eight hours. An echocardiogram on Dec 11 2005 was suggestive of pericarditis. A cardiac catheterization on Dec 12 2005 was normal. On Dec 13 2005 he had studies showing open coronary arteries, but apparent pericarditis. No treatment information was provided. At the time of this report the patient was still experiencing mild chest pain and had not recovered from the events.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Asthenia, Blood glucose decreased, Fatigue, Headache
Clinical narrative: Information has been received from a health professional concerning a 21 year old female with no known allergies and on and off chest pain beginning in 2002 (attributed to stress), and a history of sinusitis, who on 5/20/04, was vaccinated in the left arm with a 0.5mL first dose of MMR (lot # 646343/0960N). On 5/20/04, the patient was given a 0.1 dose of PPD in the left forearm. On 1/5/05, the patient presented with a history of consistent tiredness and tingling up to 2 hours/day (left greater than right thigh). No weakness seemed to resolve. In June 2004, the patient experienced extreme fatigue. At the time of this report, the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information received from a physician indicated that in the beginning of July 2004, the patient developed oral blisters. She also was noted to be ill with fatigue, rashes, head/neck pain, a tingling sensation, and weakness (noted to have recovered). She had escaped a specific diagnosis, despite numerous tests. Medical records indicated that the patient presented to the physician on 2/9/05 with multiple neurological symptoms. It was noted that beginning roughly in July 2004, the patient began to experience a series of problems, the first tingling in her lower extremities, but then went on to have symptoms of a feeling of diffuse weakness at times, a burning sensation across the right side of the head, as though she had trouble with her throat closing spontaneously, achy joints, and mostly extreme fatigue. The latter became particularly evident in the fall of 2004, when she had an axillary rash bilaterally, with itching. It was mostly a vesicular rash that had a somewhat linear vertical orientation. She had no had a rash elsewhere. Whereas her lower extremities tingling symptoms were very prominent in July 2004, lasting less that 30 minutes on a given occasion, they became much more of a persistent problem in December, and have bothered her since. In the meantime, she underwent an MRI scan of the brain which was performed on 12/28/04, without contrast. The study was normal. She also had an MRI of the thoracic spine on the same date, which was normal. During this time, she had not had any fever, though she had blood tests done, including a chemistry profile that was unremarkable, except for a fasting glucose of 61, but the subsequent glucose was 85 with normal insulin. In addition, a CBC diff was normal, and a mono screen on 1/5/05 was negative. On 2/9/05, the patient's albumin was high at 5.1g/dL. It was noted that the child had no childhood immunizations - were waived by parents. It was noted that the reaction was possible related to vaccination with MMR. The reporter indicated that the events were considered to be disabling. The reporter expressed a concern with the lot. The records of testing prior to the release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Pruritus, Rash, Rash vesicular, Skin burning sensation, Throat tightness
Clinical narrative: Information has been received from a health professional concerning a 21 year old female with no known allergies and on and off chest pain beginning in 2002 (attributed to stress), and a history of sinusitis, who on 5/20/04, was vaccinated in the left arm with a 0.5mL first dose of MMR (lot # 646343/0960N). On 5/20/04, the patient was given a 0.1 dose of PPD in the left forearm. On 1/5/05, the patient presented with a history of consistent tiredness and tingling up to 2 hours/day (left greater than right thigh). No weakness seemed to resolve. In June 2004, the patient experienced extreme fatigue. At the time of this report, the patient had not recovered. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information received from a physician indicated that in the beginning of July 2004, the patient developed oral blisters. She also was noted to be ill with fatigue, rashes, head/neck pain, a tingling sensation, and weakness (noted to have recovered). She had escaped a specific diagnosis, despite numerous tests. Medical records indicated that the patient presented to the physician on 2/9/05 with multiple neurological symptoms. It was noted that beginning roughly in July 2004, the patient began to experience a series of problems, the first tingling in her lower extremities, but then went on to have symptoms of a feeling of diffuse weakness at times, a burning sensation across the right side of the head, as though she had trouble with her throat closing spontaneously, achy joints, and mostly extreme fatigue. The latter became particularly evident in the fall of 2004, when she had an axillary rash bilaterally, with itching. It was mostly a vesicular rash that had a somewhat linear vertical orientation. She had no had a rash elsewhere. Whereas her lower extremities tingling symptoms were very prominent in July 2004, lasting less that 30 minutes on a given occasion, they became much more of a persistent problem in December, and have bothered her since. In the meantime, she underwent an MRI scan of the brain which was performed on 12/28/04, without contrast. The study was normal. She also had an MRI of the thoracic spine on the same date, which was normal. During this time, she had not had any fever, though she had blood tests done, including a chemistry profile that was unremarkable, except for a fasting glucose of 61, but the subsequent glucose was 85 with normal insulin. In addition, a CBC diff was normal, and a mono screen on 1/5/05 was negative. On 2/9/05, the patient's albumin was high at 5.1g/dL. It was noted that the child had no childhood immunizations - were waived by parents. It was noted that the reaction was possible related to vaccination with MMR. The reporter indicated that the events were considered to be disabling. The reporter expressed a concern with the lot. The records of testing prior to the release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Sex: F
Vaccine: PPV
Symptoms: Anaphylactic reaction, Injection site hypersensitivity, Injection site oedema, Injection site rash, Pruritus
Clinical narrative: Information has been received from a healthcare worker concerning a female patient who on Dec 13 2005 was vaccinated IM with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). On the same day the patient developed an anaphylactic type reaction, which included red itchy rash at injection site, and swelling also at injection site. The patient was sent to the ER, treated with a steroid methylprednisolone (Medrol Dosepak) and released. The patients outcome was unknown. The reporter considered anaphylactic type reaction, red itchy rash at injection site, and swelling at injection site to be immediately life threatening, and to be other important medical events (OMIC). Additional information has been requested.
Age: 33.0
Sex: M
Vaccine: PPV
Symptoms: Influenza like illness, Oedema, Pain
Clinical narrative: Information has been received from a registered nurse concerning a 32 year old male who on Dec 7 2005 was vaccinated IM in the left deltoid with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). On Dec 12 2005, 72 hours post vaccination, the patient experienced pain, swelling from the left deltoid to just above the elbow, and flu like symptoms. Subsequently, the patient fully recovered. Unspecified medical attention was sought. There was no product quality complaint. It was noted that the nurse requested a lot check on lot # 651318/1006P. The events were considered to be disabling. Additional information has been requested.
Age: 49.0
Sex: M
Vaccine: FLUX, PPV, TD
Symptoms: Chills, Injection site rash, Malaise, Pyrexia, Tremor
Clinical narrative: Information has been received from a physician concerning a 49 year old male financial officer with no medical history who on the morning of 11/19/05 was vaccinated in the right arm with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine therapy given in the left arm included a dose of influenza virus vaccine and a dose of diphtheria toxoid/tetanus toxoid (lot # Td143). There was no illness at the time of vaccination. Subsequently the patient developed a temperature of 104, shaking chills, malaise, and a rash area about the vaccination site. Subsequently, the patient recovered. The physician felt that temperature to 104, shaking chills, malaise and a rash area about the vaccine site were considered to be other important medical events (OMIC) because the patient missed a couple days of work. No further information is expected.
Age: 16.0
Sex: M
Vaccine: PPV
Symptoms: Axillary pain, Injection site pain, Musculoskeletal chest pain
Clinical narrative: Information has been received from a registered nurse concerning a 16 year old male with reflux disease, sensitivity to codeine and environmental allergies who on Sept 13 2005 was vaccinated with a first dose IM in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). On Sept 15 2005, two days post vaccination, the patient called the office stating that he had pain in injection site, axillary, and chest wall which lasted 4 days. The patient had also difficulty raising arm. Unspecified medical attention was sought. The patient was treated with ibuprofen (Motrin). Subsequently, the patient fully recovered on 18-SEP-2005. The registered nursed requested a lot check. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. In addition, a review of the Quality Control Quarantine/Rejection System revealed that there were no open Quarantines registered against this lot/fill. Pain at injection site, axillary and chest pain were considered to be disabling. Other business partner numbers included: E2005-05552. Additional information has been requested.
Age: 23.0
Sex: M
Vaccine: PPV
Symptoms: Abdominal pain, Erythema, Injection site hypersensitivity, Lymphadenopathy
Clinical narrative: Information has been received from a health professional concerning a 23 year old male with a morphine allergy and no pertinent medical history, who on Dec 13 2005 was vaccinated with a 0.1ml intradermal injection in the right forearm of Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). There was no concomitant medication. About 12 hours post vaccination, on Dec 14 2005, the patient developed severe arm pain and noted two red streaks on his arm. Each streak was 1/8" wide and 1-2" long. One was near the injection site and one was on his bicep. The patient also developed swelling of his axillary lymph nodes on the same side as the injection. The patient was admitted to the hospital and was started on IV antibiotics. At the time of the report the patient was recovering. There were no laboratory or diagnostic test performed. No product quality complaint was involved. No other information was provided. The event was considered to be an other important medical event by the reporter (OMIC). Additional information has been requested.
Age: 1.59
Sex: U
Vaccine: FLU3
Symptoms: Epilepsy, Pyrexia
Clinical narrative: Approximately 22 hrs after administration of influenza vaccine, status epileptic generalized, then walk in local facility. Child had brief febrile seizure previously at 10 mos, did not have fever at time of seizure but developed one later in the day,
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Anxiety, Asthenia, CSF test abnormal, Guillain-Barre syndrome, Hypoaesthesia
Clinical narrative: Numbness to both arms and hands and generalized weakness (unable to raise arm over her head on 12/9/05 and unable to get up from the floor). Referred to MD on 12/12/05 as soon as reported. Medical records state GBS, decreased reflexes, anxiety. msv
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Hypokinesia, Hyporeflexia, Laboratory test abnormal
Clinical narrative: Numbness to both arms and hands and generalized weakness (unable to raise arm over her head on 12/9/05 and unable to get up from the floor). Referred to MD on 12/12/05 as soon as reported. Medical records state GBS, decreased reflexes, anxiety. msv
Age: 59.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Dysarthria, Eye disorder, Facial palsy, Facial palsy, Lacrimation increased
Clinical narrative: On 10/27/2005 received Fluzone vaccine for flu prevention at work. On 12/02/2005, employee noticed tearing in left eye excessive, followed by left sided facial paralysis. Other serious important medical events (OMIC). Patient/employee still is having drooping of mouth (L) and some speech slurring. Is still attending speech therapy clases. no real improvement in condition.
Age: 59.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Facial palsy, Lacrimation increased, Nervous system disorder
Clinical narrative: On 10/27/2005 received Fluzone vaccine for flu prevention at work. On 12/02/2005, employee noticed tearing in left eye excessive, followed by left sided facial paralysis. Other serious important medical events (OMIC). Patient/employee still is having drooping of mouth (L) and some speech slurring. Is still attending speech therapy clases. no real improvement in condition.
Age: 41.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Agitation, Anxiety, CSF test abnormal, Chills, Confusional state
Clinical narrative: Reports having body aches early in AM so much so that he was unable to complete his normal work out at the gym. He went home to lie down only to awake later that evening with chills, fever, and some mental confusion (his wife reported that he was holding his hand out as if holding a cup but there was no cup there. She called and was advised to give Motrin q 8 hours alternating with Tylenol q 4-6 hours. The confusion and somnolence increased and she again called, spoke with MD who advised to take to ER. He was evaluated at ER, Rx'd with IV's for dehydration and released. Early the next morning, he became increasingly confused and somnolent and developed fecal incontinence. She again called and was advised by he MD to call 911 and return to the ER. He was evaluated there CT scan, MRI and a spinal tap was accomplished that was positive for elevated protein and 20 cells. A consult was obtained and it was decided that VIG was not indicated and the member was transferred to another hospital's ICU. 1/4/06 D/C summary indicates final diagnosis was post-vaccine encephalitis.  1/4/06 Review of medical indicates additional symptoms/conditions include altered mental status, seizure followed by apnea, tachycardia  due to anxiety/agitation, and ataxia.
Age: 41.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Convulsion, Coordination abnormal, Dehydration, Encephalitis, Faecal incontinence
Clinical narrative: Reports having body aches early in AM so much so that he was unable to complete his normal work out at the gym. He went home to lie down only to awake later that evening with chills, fever, and some mental confusion (his wife reported that he was holding his hand out as if holding a cup but there was no cup there. She called and was advised to give Motrin q 8 hours alternating with Tylenol q 4-6 hours. The confusion and somnolence increased and she again called, spoke with MD who advised to take to ER. He was evaluated at ER, Rx'd with IV's for dehydration and released. Early the next morning, he became increasingly confused and somnolent and developed fecal incontinence. She again called and was advised by he MD to call 911 and return to the ER. He was evaluated there CT scan, MRI and a spinal tap was accomplished that was positive for elevated protein and 20 cells. A consult was obtained and it was decided that VIG was not indicated and the member was transferred to another hospital's ICU. 1/4/06 D/C summary indicates final diagnosis was post-vaccine encephalitis.  1/4/06 Review of medical indicates additional symptoms/conditions include altered mental status, seizure followed by apnea, tachycardia  due to anxiety/agitation, and ataxia.
Age: 41.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Hypokinesia, Laboratory test abnormal, Pain, Pyrexia, Somnolence
Clinical narrative: Reports having body aches early in AM so much so that he was unable to complete his normal work out at the gym. He went home to lie down only to awake later that evening with chills, fever, and some mental confusion (his wife reported that he was holding his hand out as if holding a cup but there was no cup there. She called and was advised to give Motrin q 8 hours alternating with Tylenol q 4-6 hours. The confusion and somnolence increased and she again called, spoke with MD who advised to take to ER. He was evaluated at ER, Rx'd with IV's for dehydration and released. Early the next morning, he became increasingly confused and somnolent and developed fecal incontinence. She again called and was advised by he MD to call 911 and return to the ER. He was evaluated there CT scan, MRI and a spinal tap was accomplished that was positive for elevated protein and 20 cells. A consult was obtained and it was decided that VIG was not indicated and the member was transferred to another hospital's ICU. 1/4/06 D/C summary indicates final diagnosis was post-vaccine encephalitis.  1/4/06 Review of medical indicates additional symptoms/conditions include altered mental status, seizure followed by apnea, tachycardia  due to anxiety/agitation, and ataxia.
Age: 41.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP
Symptoms: Tachycardia
Clinical narrative: Reports having body aches early in AM so much so that he was unable to complete his normal work out at the gym. He went home to lie down only to awake later that evening with chills, fever, and some mental confusion (his wife reported that he was holding his hand out as if holding a cup but there was no cup there. She called and was advised to give Motrin q 8 hours alternating with Tylenol q 4-6 hours. The confusion and somnolence increased and she again called, spoke with MD who advised to take to ER. He was evaluated at ER, Rx'd with IV's for dehydration and released. Early the next morning, he became increasingly confused and somnolent and developed fecal incontinence. She again called and was advised by he MD to call 911 and return to the ER. He was evaluated there CT scan, MRI and a spinal tap was accomplished that was positive for elevated protein and 20 cells. A consult was obtained and it was decided that VIG was not indicated and the member was transferred to another hospital's ICU. 1/4/06 D/C summary indicates final diagnosis was post-vaccine encephalitis.  1/4/06 Review of medical indicates additional symptoms/conditions include altered mental status, seizure followed by apnea, tachycardia  due to anxiety/agitation, and ataxia.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Swelling, Tenderness
Clinical narrative: Swelling, redness left thigh. Tenderness
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Throat tightness
Clinical narrative: Approx at 10:55 c/o sob and feelings of something in her throat. A/0X3 no immediate distress of any observed. Benadryl 25 mg IV given by EMS. Pt recovered d/c to home per coworker on 12/16/05.
Age: 77.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Insomnia, Joint stiffness, Oedema, Pain
Clinical narrative: Received vaccine, started 4 hours later noted arm "soreness," increasing in pain affecting ability to sleep. In morning took 2 advil which helped pain. Arm was swollen that even it difficult to bend arm, Noticed redness of arm the next day. Returned to SCHD 11/21, 3 pm. Arm red, edematous distal to injection site - from half way above elbow. Pain and mobility are restarted. Advised appt with doctor. Treated with antihistamine and ATB.
Age: 65.0
Sex: F
Vaccine: PPV, TD
Symptoms: Headache, Injection site erythema, Injection site oedema
Clinical narrative: Erythema and edema at injection site ( 20 cm diameter ) fever/chills, headache, temp 98.9 degrees after treatment with tylenol
Age: 32.0
Sex: M
Vaccine: FLUN3, SMALL, TYP
Symptoms: Exfoliative rash, Rash maculo-papular, Skin ulcer
Clinical narrative: Symptoms - diffuse rash on scalp, neck, upper chest and behind ears. Signs - macular, papular, pretubal rash sparing hands, lower extr. and lower abdomen; pustular lesions were only on the neck, no ulcerations/blisters/scale/oozing. Not oily or flaky in appearnce. Non-pruritic. Time - 10 days past small pox vaccianation  Treatment - cloberasol 0.054 solution to scalp; triamcinalone 0.1% cream to other regions.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Flushing, Urticaria, Wheezing
Clinical narrative: 0950 pt sitting flushed face, slight wheezing bilaterally anterior/posterior like. B/P 178/98 p 120 R- 28 Treated with albuterol duffs- self admin. wheezing decreased. 0958 BP 180/110 AP - 64 R - 26. Hives left shoulder area noticed at 1000. Epin 1:1000.3 given right arm SQ, wheezes increased bilat. Medical ambulance called 1/20: Spoke with Dr. at hospital ED 11:20. Patient to be D/C'd from ED and doing well.
Age: 0.75
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Pt given flu shot and returned about 15 min later covered with hives. No respiratory distress. Gave nebulizer treated with Xopenex 0.63mg, 4mg Decadron IM, 0.1 ml of Epinephrine 1:1000 mg hives resolved after about 30 min.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Cough, Nasal congestion, Otitis media, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: Sore throat, congestion, cough, fever, severe bilateral otitis media with perforation.
Age: 43.0
Sex: M
Vaccine: FLU3, TD
Symptoms: Dizziness, Fatigue, Influenza like illness, Injection site erythema, Injection site oedema
Clinical narrative: Mild swelling, redness, tenderness at Td site. Flu like symptoms: body aches, fatigue, dizziness) Most symptoms lasted 4 days. Soreness in left arm lasted one week.
Age: 43.0
Sex: M
Vaccine: FLU3, TD
Symptoms: Pain, Tenderness
Clinical narrative: Mild swelling, redness, tenderness at Td site. Flu like symptoms: body aches, fatigue, dizziness) Most symptoms lasted 4 days. Soreness in left arm lasted one week.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Abdominal discomfort, Eye disorder, Hyperhidrosis, Malaise, Vision blurred
Clinical narrative: 16-18 hour after receipt- "deathly ill" - cold sweats, "stomach convulsions" ie vomiting, eyes would not stop rotating. eyes couldn't focus, blurred vision. Eyes still blurry, stomach still upset.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: 16-18 hour after receipt- "deathly ill" - cold sweats, "stomach convulsions" ie vomiting, eyes would not stop rotating. eyes couldn't focus, blurred vision. Eyes still blurry, stomach still upset.
Age: 5.0
Sex: F
Vaccine: DTAP, FLU3, HEPA, IPV, MMR
Symptoms: Cellulitis, Erythema, Oedema
Clinical narrative: 12/01/05 Phone call: Mom states right arm swollen twice as big as left arm. Advised appt. 12/05/05 office visit: right arm redness, swelling, mild cellulitis likely vaccine related.
Age: 26.0
Sex: F
Vaccine: FLUN3
Symptoms: Nausea, Vomiting
Clinical narrative: Immediately after receiving flumist, pt felt nausea and vomited once. She subsequently felt progressively better.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Pyrexia
Clinical narrative: Awoke 11:00 pm with high fever and body aches. Did not feel good enough to take temp until 5:00 am. Temp 100.8. At 6:00 am temp down to 100.0. Had low grade fever and minor body aches until around 12/18/05 12:00 noon. Treatment : 3 doses of 1000 mg tylenol 12/17/05.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Break out in rash covering body from face to knees. Comes back approximately every 6 days. Treatment- 2 benedryl tablets
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Syncope
Clinical narrative: Influenza vaccine administered. Patient got up and walked across room and fainted; several minutes later. She woke up 2-3 seconds later and became alert.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Child started vomiting 1 1/2 hr after shot and continued to vomit every 15 minutes from 2:30 - 6:30 pm and gave emetrol and vomiting stopped.
Age: 25.0
Sex: F
Vaccine: FLU3, TD
Symptoms: Hypokinesia, Myalgia, Pain
Clinical narrative: States "Flu Shot" given in right deltoid. Right shoulder sore cannot raise above shoulder level without pain - injection given 3 weeks prior and symptoms have been present since injection (next am).
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Client call c/o redness, pain, swelling on her left arm. The redness start from the site extended under arm to above elbow about hand sized after 24 to 48 hours after administration.
Age: 1.19
Sex: M
Vaccine: FLU3, HIBV, MMR, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: 14 mo male had MMR and varicella immunization 11/21/05. 11/29/05 had fever 101.9 degrees and minimal seizure . W/U and exams at the time was not revealing a source of infection. ? ear infection, Rocephin was given IM. Parents have continued to monitor temperature every time the diaper is changed. In the evening pt has 100.4-101.4 temp. No other symptoms. No crying, appetite good, normal BM, playing normally, gaining wt. No vomiting, diarrhea, pulling ears, or cough. Fever non specific. Rash could represent modified measles infection from the immunization. No evidence of encephalitis at present. CDC description of fever from measles is short deviation (2-3 day), varicella has also been described as producing a fever. Pt not toxic and the rash may be from any number of wild viruses in the community. Teething may give febrile reaction. Parents continue to be concerned so will give Zithromax for possible occult infection. Without more than occasional  fever would not advocate spinal fluid analysis, blood cult or repeat blood w/u.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Hives on arms, face, upper back occurred about 24 hr after influenza vaccine was given. No respiratory symptoms.
Age: 51.0
Sex: F
Vaccine: FLUX
Symptoms: Dizziness postural, Pruritus, Syncope
Clinical narrative: Patient received flu vaccine 11/16/05. Later that evening became dizzy, felt "fluttering" sensation in right breast and fainted. Also felt "itchy." S/S continued next day, though decreased and with no fainting. Urged pt to go to Urgent Care.
Age: 55.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Erythema, Feeling hot, Pain
Clinical narrative: Immunized afternoon of 12/10/05. Afternoon 12/17/05 developed arm pain, body aches worsened 12/18/05 - developed redness/warmth. Circumferential diagonal  around 2/3 of upper arm - pm of 12/19 started to have some improvement. Recommended Aleve 2 BID and heat.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Hypokinesia, Myalgia, Pain
Clinical narrative: 11/11/05 Within the following week I could not raise my arm in a certain direction due to the pain that I felt in my muscle. By 12/8 the pain was now in my armpit, down the inside of the arm and slightly across top part of left breast. Went for EKG OK. Dr Rx cephalexin helped to rid the lymph glands of infection. But the muscle still has not recovered. Improved but still very sore.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site reaction, Rash
Clinical narrative: 10 cm elevated rash at injection site. 3 cm purple area in center.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema
Clinical narrative: Erythemic wheal at injection site 2cm diameter.
Age: 42.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Paraesthesia
Clinical narrative: 4 days after injection, soreness with tingling in the thumb (left side)
Sex: F
Vaccine: FLU3
Symptoms: Injection site mass, Skin warm
Clinical narrative: Warm to the touch, egg size lump on arm.
Sex: F
Vaccine: FLU3
Symptoms: Headache, Malaise, Pain, Stomach discomfort, Vertigo
Clinical narrative: Got flu shot appox 08:45 am 5-10 min later left arm was throbbing from shoulder to tips of fingers. About 1 hour after flu shot she began to feel ill. Headache started- took advil to try to avoid. Stomach was upset - Ran fever and got the chills. About 1 hour later, room began to spin. Thought she was going to pass out. Went home where she did become ill and then fell asleep. Slept until evening. Felt better Saturday.
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Anxiety, Arthralgia, Cerebral infarction, Depression, Gastrooesophageal reflux disease
Clinical narrative: 1) acid reflux 2) ache joints 3) high cholesterol 4) depression 5) headaches 6)  ringing in the ears 7) insomnia 8) transoparietal subcortical infarct 9) anxiety
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Headache, Hypercholesterolaemia, Insomnia, Tinnitus
Clinical narrative: 1) acid reflux 2) ache joints 3) high cholesterol 4) depression 5) headaches 6)  ringing in the ears 7) insomnia 8) transoparietal subcortical infarct 9) anxiety
Age: 42.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Acne, Arthropathy, Diabetes mellitus, Gastrooesophageal reflux disease, Hypertension
Clinical narrative: Check all the documents from VA clinic. Report of confirmed degenerative joint disease, hypertension, Diabetes Type II September 2003. Additional problems include thyroid nodule, gastric reflex, osteopenia, and acne. Receives partial compensation for service related problems.
Age: 42.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Thyroid neoplasm
Clinical narrative: Check all the documents from VA clinic. Report of confirmed degenerative joint disease, hypertension, Diabetes Type II September 2003. Additional problems include thyroid nodule, gastric reflex, osteopenia, and acne. Receives partial compensation for service related problems.
Age: 33.0
Sex: M
Vaccine: SMALL
Symptoms: Fatigue, Insomnia, Lymphadenopathy, Pain
Clinical narrative: Patient complained of pain in left arm, fatigue, swollen lymph nodes and difficulty sleeping. He lost 1 duty day and given pain medicine.
Age: 21.0
Sex: M
Vaccine: HEPA
Symptoms: Dizziness
Clinical narrative: At 7:54 am, patient received Hep A (2) vaccine. He was normal at the time of vaccine (no reactions). Patient sat in the waiting room post-shot after approximately 15 minutes he stated he felt dizzy- he stood- walked for a few minutes and then indicated to us he was dizzy. We administered O2, muffin and juice. Pt. recumbant for 15 minutes until symptoms subsided.
Age: 27.0
Sex: F
Vaccine: TD
Symptoms: Erythema
Clinical narrative: 3.5 cm area of erydema 36 hours after injection. Plan to hot pack. If not improving Keflex 500 mg  BD X 10 day. Area did not increase in size. Did not take antibiotic.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Feeling hot
Clinical narrative: Redness and warm clearly defined outlined. No pain or fever.
Age: 6.0
Sex: F
Vaccine: IPV, MMR
Symptoms: Rash vesicular
Clinical narrative: Developed rash/symptoms of varicella in outbreak situation
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Rash vesicular
Clinical narrative: Developed rash/symptoms typical of varicella in outbreak situation
Sex: M
Vaccine: HEP
Symptoms: Rash morbilliform
Clinical narrative: Seen 11/14 for 1 day history of evolving well demarcated rash  with initial Dx it multiforme. Received 2 days later revealed rash that was changing in location . Not hives. No new skin. Antibac PO intake. No fever. Not ill.
Age: 1.05
Sex: F
Vaccine: DTAP, HBPV, IPV, MMR
Symptoms: Unevaluable event
Clinical narrative: Blank
Age: 9.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Rash vesicular
Clinical narrative: Had varicella symptoms and rash in outbreak situation
Age: 1.31
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Rash vesicular
Clinical narrative: Had rash/symptoms consistant with varicella in outbreak situation.
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Pyrexia
Clinical narrative: Fever 104 x 4 days.